Breaking News

Monday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Amwell price target raised to $45 from $44 at Piper Sandler » 04:51
02/22/21
02/22
04:51
02/22/21
04:51
AMWL

Amwell

$30.17 /

+0.025 (+0.08%)

Piper Sandler analyst…

Piper Sandler analyst Sean Wieland raised the firm's price target on Amwell to $45 from $44 and reiterates an Overweight rating on the shares. The analyst believes virtual primary care will allow Amwell to play a "meaningful role" in "Primary Care V2.0." The company's app enabled solution is "uniquely capable" of facilitating the outbound interventions, Wieland tells investors in a research note.

ShowHide Related Items >><<
AMWL Amwell
$30.17 /

+0.025 (+0.08%)

AMWL Amwell
$30.17 /

+0.025 (+0.08%)

01/27/21 Credit Suisse
Amwell downgraded to Neutral from Outperform at Credit Suisse
01/06/21 BTIG
Amwell initiated with a Neutral at BTIG
12/17/20 Stifel
Amwell initiated with a Hold at Stifel
11/19/20 Morgan Stanley
Morgan Stanley upgraded Amwell on 'compelling' risk/reward after selloff
AMWL Amwell
$30.17 /

+0.025 (+0.08%)

  • 15
    Jan
  • 17
    Sep
AMWL Amwell
$30.17 /

+0.025 (+0.08%)

AMWL Amwell
$30.17 /

+0.025 (+0.08%)

AMWL Amwell
$30.17 /

+0.025 (+0.08%)

Over a month ago
Downgrade
Amwell downgraded to Neutral from Outperform at Credit Suisse » 20:01
01/27/21
01/27
20:01
01/27/21
20:01
AMWL

Amwell

$42.83 /

+4.78 (+12.56%)

Credit Suisse analyst…

Credit Suisse analyst Jailendra Singh downgraded Amwell to Neutral from Outperform with a $41 price target. The stock is up 69% year-to-date and now trades at 39.6-times and 31-times his expected FY21 and FY22 revenue estimates, the analyst tells investors in a research note. The rally has come despite any change in underlying fundamentals, and appears to have been driven by broader market activity with the names with high short interest, Singh adds.

ShowHide Related Items >><<
AMWL Amwell
$42.83 /

+4.78 (+12.56%)

AMWL Amwell
$42.83 /

+4.78 (+12.56%)

01/06/21 BTIG
Amwell initiated with a Neutral at BTIG
12/17/20 Stifel
Amwell initiated with a Hold at Stifel
11/19/20 Morgan Stanley
Morgan Stanley upgraded Amwell on 'compelling' risk/reward after selloff
11/18/20 Morgan Stanley
Amwell upgraded to Overweight from Equal Weight at Morgan Stanley
AMWL Amwell
$42.83 /

+4.78 (+12.56%)

  • 15
    Jan
  • 17
    Sep
AMWL Amwell
$42.83 /

+4.78 (+12.56%)

AMWL Amwell
$42.83 /

+4.78 (+12.56%)

AMWL Amwell
$42.83 /

+4.78 (+12.56%)

Hot Stocks
American Well Corp trading resumes  10:04
01/27/21
01/27
10:04
01/27/21
10:04
AMWL

Amwell

$39.94 /

+1.89 (+4.97%)

 
ShowHide Related Items >><<
AMWL Amwell
$39.94 /

+1.89 (+4.97%)

AMWL Amwell
$39.94 /

+1.89 (+4.97%)

01/06/21 BTIG
Amwell initiated with a Neutral at BTIG
12/17/20 Stifel
Amwell initiated with a Hold at Stifel
11/19/20 Morgan Stanley
Morgan Stanley upgraded Amwell on 'compelling' risk/reward after selloff
11/18/20 Morgan Stanley
Amwell upgraded to Overweight from Equal Weight at Morgan Stanley
AMWL Amwell
$39.94 /

+1.89 (+4.97%)

  • 15
    Jan
  • 17
    Sep
AMWL Amwell
$39.94 /

+1.89 (+4.97%)

AMWL Amwell
$39.94 /

+1.89 (+4.97%)

AMWL Amwell
$39.94 /

+1.89 (+4.97%)

Hot Stocks
American Well Corp trading halted, volatility trading pause  09:59
01/27/21
01/27
09:59
01/27/21
09:59
AMWL

Amwell

$39.04 /

+0.99 (+2.60%)

 
ShowHide Related Items >><<
AMWL Amwell
$39.04 /

+0.99 (+2.60%)

AMWL Amwell
$39.04 /

+0.99 (+2.60%)

01/06/21 BTIG
Amwell initiated with a Neutral at BTIG
12/17/20 Stifel
Amwell initiated with a Hold at Stifel
11/19/20 Morgan Stanley
Morgan Stanley upgraded Amwell on 'compelling' risk/reward after selloff
11/18/20 Morgan Stanley
Amwell upgraded to Overweight from Equal Weight at Morgan Stanley
AMWL Amwell
$39.04 /

+0.99 (+2.60%)

  • 15
    Jan
  • 17
    Sep
AMWL Amwell
$39.04 /

+0.99 (+2.60%)

AMWL Amwell
$39.04 /

+0.99 (+2.60%)

AMWL Amwell
$39.04 /

+0.99 (+2.60%)

Hot Stocks
Amwell CFO sells over 222,000 class A common shares » 16:35
01/22/21
01/22
16:35
01/22/21
16:35
AMWL

Amwell

$29.46 /

+0.285 (+0.98%)

In a regulatory filing,…

In a regulatory filing, American Well CFO Keith Anderson disclosed the sale of 222,054 class A common shares of the company on January 20 at a price of $26.4275 per share.

ShowHide Related Items >><<
AMWL Amwell
$29.46 /

+0.285 (+0.98%)

AMWL Amwell
$29.46 /

+0.285 (+0.98%)

01/06/21 BTIG
Amwell initiated with a Neutral at BTIG
12/17/20 Stifel
Amwell initiated with a Hold at Stifel
11/19/20 Morgan Stanley
Morgan Stanley upgraded Amwell on 'compelling' risk/reward after selloff
11/18/20 Morgan Stanley
Amwell upgraded to Overweight from Equal Weight at Morgan Stanley
AMWL Amwell
$29.46 /

+0.285 (+0.98%)

  • 15
    Jan
  • 17
    Sep
AMWL Amwell
$29.46 /

+0.285 (+0.98%)

AMWL Amwell
$29.46 /

+0.285 (+0.98%)

AMWL Amwell
$29.46 /

+0.285 (+0.98%)

Syndicate
Amwell 11.281M share Secondary priced at $27.50 » 23:08
01/14/21
01/14
23:08
01/14/21
23:08
AMWL

Amwell

$28.70 /

+3.45 (+13.67%)

The deal priced below the…

The deal priced below the last closing price of $28.70. Morgan Stanley, Goldman Sachs, Piper Sandler and UBS are acting as joint book running managers for the offering.

ShowHide Related Items >><<
AMWL Amwell
$28.70 /

+3.45 (+13.67%)

AMWL Amwell
$28.70 /

+3.45 (+13.67%)

01/06/21 BTIG
Amwell initiated with a Neutral at BTIG
12/17/20 Stifel
Amwell initiated with a Hold at Stifel
11/19/20 Morgan Stanley
Morgan Stanley upgraded Amwell on 'compelling' risk/reward after selloff
11/18/20 Morgan Stanley
Amwell upgraded to Overweight from Equal Weight at Morgan Stanley
AMWL Amwell
$28.70 /

+3.45 (+13.67%)

  • 15
    Jan
  • 17
    Sep
AMWL Amwell
$28.70 /

+3.45 (+13.67%)

AMWL Amwell
$28.70 /

+3.45 (+13.67%)

AMWL Amwell
$28.70 /

+3.45 (+13.67%)

Syndicate
Amwell announces offering of 11.28M shares of Class A common stock for holders » 16:37
01/12/21
01/12
16:37
01/12/21
16:37
AMWL

Amwell

$26.29 /

-0.08 (-0.30%)

Morgan Stanley, Goldman…

Morgan Stanley, Goldman Sachs & Co., Piper Sandler and UBS Investment Bank are acting as lead joint book-running managers for the proposed offering. Credit Suisse, Cowen and Berenberg are acting as bookrunners for the proposed offering.

ShowHide Related Items >><<
AMWL Amwell
$26.29 /

-0.08 (-0.30%)

AMWL Amwell
$26.29 /

-0.08 (-0.30%)

01/06/21 BTIG
Amwell initiated with a Neutral at BTIG
12/17/20 Stifel
Amwell initiated with a Hold at Stifel
11/19/20 Morgan Stanley
Morgan Stanley upgraded Amwell on 'compelling' risk/reward after selloff
11/18/20 Morgan Stanley
Amwell upgraded to Overweight from Equal Weight at Morgan Stanley
AMWL Amwell
$26.29 /

-0.08 (-0.30%)

  • 17
    Sep
AMWL Amwell
$26.29 /

-0.08 (-0.30%)

AMWL Amwell
$26.29 /

-0.08 (-0.30%)

AMWL Amwell
$26.29 /

-0.08 (-0.30%)

Initiation
Amwell initiated with a Neutral at BTIG » 16:24
01/06/21
01/06
16:24
01/06/21
16:24
AMWL

Amwell

$25.67 /

-0.07 (-0.27%)

BTIG analyst David Larsen…

BTIG analyst David Larsen initiated coverage of Amwell with a Neutral rating and no price target. While the COVID-19 pandemic has accelerated the use of tele-medicine and driven demand up to peak levels, he has concerns about valuation and the potential for Amwell to face greater competition, Larsen tells investors.

ShowHide Related Items >><<
AMWL Amwell
$25.67 /

-0.07 (-0.27%)

AMWL Amwell
$25.67 /

-0.07 (-0.27%)

12/17/20 Stifel
Amwell initiated with a Hold at Stifel
11/19/20 Morgan Stanley
Morgan Stanley upgraded Amwell on 'compelling' risk/reward after selloff
11/18/20 Morgan Stanley
Amwell upgraded to Overweight from Equal Weight at Morgan Stanley
10/23/20 Guggenheim
Amwell initiated with a Neutral at Guggenheim
AMWL Amwell
$25.67 /

-0.07 (-0.27%)

  • 17
    Sep
AMWL Amwell
$25.67 /

-0.07 (-0.27%)

AMWL Amwell
$25.67 /

-0.07 (-0.27%)

AMWL Amwell
$25.67 /

-0.07 (-0.27%)

Conference/Events
Piper Sandler healthcare services analysts hold analyst/industry conference call » 10:25
12/22/20
12/22
10:25
12/22/20
10:25
ACCD

Accolade

$53.75 /

+4.14 (+8.35%)

, AMWL

Amwell

$28.76 /

+1.62 (+5.97%)

, ONEM

1Life Healthcare

$42.51 /

+1 (+2.41%)

, TDOC

Teladoc

$206.80 /

+7.24 (+3.63%)

Healthcare…

Healthcare Services/Information Technology Analysts Wieland, Tassan & Shea, along with Fred Kopplow, Director of Digital Marketing at Blue Cross/Blue Shield of Michigan, discuss Digital Health strategy at BCBS and what it means for ACCD, AMWL, ONEM and TDOC on an Analyst/Industry conference call to be held on December 22 at 11 am.

ShowHide Related Items >><<
TDOC Teladoc
$206.80 /

+7.24 (+3.63%)

ONEM 1Life Healthcare
$42.51 /

+1 (+2.41%)

AMWL Amwell
$28.76 /

+1.62 (+5.97%)

ACCD Accolade
$53.75 /

+4.14 (+8.35%)

12/08/20
Fly Intel: Top five analyst initiations
12/08/20 Canaccord
Accolade initiated with a Buy at Canaccord
11/16/20 Stifel
Accolade initiated with a Buy at Stifel
10/15/20 DA Davidson
Accolade price target raised to $50 from $45 at DA Davidson
AMWL Amwell
$28.76 /

+1.62 (+5.97%)

12/17/20 Stifel
Amwell initiated with a Hold at Stifel
11/19/20 Morgan Stanley
Morgan Stanley upgraded Amwell on 'compelling' risk/reward after selloff
11/18/20 Morgan Stanley
Amwell upgraded to Overweight from Equal Weight at Morgan Stanley
10/23/20 Guggenheim
Amwell initiated with a Neutral at Guggenheim
ONEM 1Life Healthcare
$42.51 /

+1 (+2.41%)

12/16/20 Baird
Baird would be a buyer of Teladoc amid weakness caused by Amazon report
12/16/20 Deutsche Bank
1Life Healthcare price target raised to $42 from $38 at Deutsche Bank
12/16/20 Canaccord
1Life Healthcare price target raised to $46 from $41 at Canaccord
11/16/20 Truist
1Life Healthcare price target raised to $40 from $36 at Truist
TDOC Teladoc
$206.80 /

+7.24 (+3.63%)

12/22/20 Evercore ISI
Teladoc initiated with an In Line at Evercore ISI
12/17/20 Craig-Hallum
Teladoc price target raised to $212 from $200 at Craig-Hallum
12/07/20 Stephens
Stephens downgrades Teladoc to Equal Weight amid increased competition
TDOC Teladoc
$206.80 /

+7.24 (+3.63%)

ONEM 1Life Healthcare
$42.51 /

+1 (+2.41%)

AMWL Amwell
$28.76 /

+1.62 (+5.97%)

ACCD Accolade
$53.75 /

+4.14 (+8.35%)

  • 23
    Nov
  • 22
    Oct
  • 17
    Sep
  • 02
    Jul
  • 25
    Jun
  • 31
    Jan
TDOC Teladoc
$206.80 /

+7.24 (+3.63%)

AMWL Amwell
$28.76 /

+1.62 (+5.97%)

TDOC Teladoc
$206.80 /

+7.24 (+3.63%)

ONEM 1Life Healthcare
$42.51 /

+1 (+2.41%)

AMWL Amwell
$28.76 /

+1.62 (+5.97%)

ACCD Accolade
$53.75 /

+4.14 (+8.35%)

TDOC Teladoc
$206.80 /

+7.24 (+3.63%)

ONEM 1Life Healthcare
$42.51 /

+1 (+2.41%)

AMWL Amwell
$28.76 /

+1.62 (+5.97%)

ACCD Accolade
$53.75 /

+4.14 (+8.35%)

Conference/Events
Piper Sandler healthcare services analysts hold analyst/industry conference call » 04:55
12/22/20
12/22
04:55
12/22/20
04:55
ACCD

Accolade

$49.61 /

-1.27 (-2.50%)

, AMWL

Amwell

$27.14 /

+ (+0.00%)

, ONEM

1Life Healthcare

$41.51 /

+1.27 (+3.16%)

, TDOC

Teladoc

$199.56 /

+3.88 (+1.98%)

Healthcare…

Healthcare Services/Information Technology Analysts Wieland, Tassan & Shea, along with Fred Kopplow, Director of Digital Marketing at Blue Cross/Blue Shield of Michigan, discuss Digital Health strategy at BCBS and what it means for ACCD, AMWL, ONEM and TDOC on an Analyst/Industry conference call to be held on December 22 at 11 am.

ShowHide Related Items >><<
TDOC Teladoc
$199.56 /

+3.88 (+1.98%)

ONEM 1Life Healthcare
$41.51 /

+1.27 (+3.16%)

AMWL Amwell
$27.14 /

+ (+0.00%)

ACCD Accolade
$49.61 /

-1.27 (-2.50%)

12/08/20
Fly Intel: Top five analyst initiations
12/08/20 Canaccord
Accolade initiated with a Buy at Canaccord
11/16/20 Stifel
Accolade initiated with a Buy at Stifel
10/15/20 DA Davidson
Accolade price target raised to $50 from $45 at DA Davidson
AMWL Amwell
$27.14 /

+ (+0.00%)

12/17/20 Stifel
Amwell initiated with a Hold at Stifel
11/19/20 Morgan Stanley
Morgan Stanley upgraded Amwell on 'compelling' risk/reward after selloff
11/18/20 Morgan Stanley
Amwell upgraded to Overweight from Equal Weight at Morgan Stanley
10/23/20 Guggenheim
Amwell initiated with a Neutral at Guggenheim
ONEM 1Life Healthcare
$41.51 /

+1.27 (+3.16%)

12/16/20 Baird
Baird would be a buyer of Teladoc amid weakness caused by Amazon report
12/16/20 Deutsche Bank
1Life Healthcare price target raised to $42 from $38 at Deutsche Bank
12/16/20 Canaccord
1Life Healthcare price target raised to $46 from $41 at Canaccord
11/16/20 Truist
1Life Healthcare price target raised to $40 from $36 at Truist
TDOC Teladoc
$199.56 /

+3.88 (+1.98%)

12/17/20 Craig-Hallum
Teladoc price target raised to $212 from $200 at Craig-Hallum
12/07/20 Stephens
Stephens downgrades Teladoc to Equal Weight amid increased competition
12/07/20 Stephens
Teladoc downgraded to Equal Weight from Overweight at Stephens
TDOC Teladoc
$199.56 /

+3.88 (+1.98%)

ONEM 1Life Healthcare
$41.51 /

+1.27 (+3.16%)

AMWL Amwell
$27.14 /

+ (+0.00%)

ACCD Accolade
$49.61 /

-1.27 (-2.50%)

  • 23
    Nov
  • 22
    Oct
  • 17
    Sep
  • 02
    Jul
  • 25
    Jun
  • 31
    Jan
TDOC Teladoc
$199.56 /

+3.88 (+1.98%)

AMWL Amwell
$27.14 /

+ (+0.00%)

TDOC Teladoc
$199.56 /

+3.88 (+1.98%)

ONEM 1Life Healthcare
$41.51 /

+1.27 (+3.16%)

AMWL Amwell
$27.14 /

+ (+0.00%)

ACCD Accolade
$49.61 /

-1.27 (-2.50%)

TDOC Teladoc
$199.56 /

+3.88 (+1.98%)

ONEM 1Life Healthcare
$41.51 /

+1.27 (+3.16%)

AMWL Amwell
$27.14 /

+ (+0.00%)

ACCD Accolade
$49.61 /

-1.27 (-2.50%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.